Triple Combination DAAs for Treating HCV GT1b Subjects

NCT02932293 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The collaborating pharmaceutical company will not wish to continue with the trial due to the internal issues in the company.

Conditions

Interventions

Sponsor

Humanity and Health Research Centre

Collaborators